156 related articles for article (PubMed ID: 14570342)
1. Equal effectiveness of older traditional antibiotics and newer broad-spectrum antibiotics in treating patients with acute exacerbations of chronic bronchitis.
Peng CC; Aspinall SL; Good CB; Atwood CW; Chang CC
South Med J; 2003 Oct; 96(10):986-91. PubMed ID: 14570342
[TBL] [Abstract][Full Text] [Related]
2. Antibiotics in the treatment of acute exacerbations of chronic bronchitis.
Dever LL; Shashikumar K; Johanson WG
Expert Opin Investig Drugs; 2002 Jul; 11(7):911-25. PubMed ID: 12084002
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and cost-effectiveness of antibiotic treatments for community acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB).
Lavoie F; Blais L; Castilloux AM; Scalera A; LeLorier J
Can J Clin Pharmacol; 2005; 12(2):e212-7. PubMed ID: 15998960
[TBL] [Abstract][Full Text] [Related]
4. The diagnosis and treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease and chronic bronchitis.
Albertson TE; Louie S; Chan AL
J Am Geriatr Soc; 2010 Mar; 58(3):570-9. PubMed ID: 20398122
[TBL] [Abstract][Full Text] [Related]
5. Costs of treating lower respiratory tract infections.
Monte SV; Paolini NM; Slazak EM; Schentag JJ; Paladino JA
Am J Manag Care; 2008 Apr; 14(4):190-6. PubMed ID: 18402511
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of ambulatory acute exacerbations of chronic bronchitis with older versus newer antimicrobials.
Madaras-Kelly KJ; Magdanz SB; Johnson CK; Jue SG
Ann Pharmacother; 2002 Jun; 36(6):975-80. PubMed ID: 12022895
[TBL] [Abstract][Full Text] [Related]
7. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.
Grossman R; Mukherjee J; Vaughan D; Eastwood C; Cook R; LaForge J; Lampron N
Chest; 1998 Jan; 113(1):131-41. PubMed ID: 9440580
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis.
Wilson R; Jones P; Schaberg T; Arvis P; Duprat-Lomon I; Sagnier PP;
Thorax; 2006 Apr; 61(4):337-42. PubMed ID: 16449273
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics in acute exacerbations of chronic bronchitis.
Sethi S
Expert Rev Anti Infect Ther; 2010 Apr; 8(4):405-17. PubMed ID: 20377336
[TBL] [Abstract][Full Text] [Related]
10. Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis.
Milstone A; Patsimas J; Farzan D; Castaldo R; Singh H; Feurer I; Harnett J; Luke DR;
Clin Ther; 2005 Jun; 27(6):926-39. PubMed ID: 16117993
[TBL] [Abstract][Full Text] [Related]
11. Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD.
Anzueto A; Miravitlles M
Respir Med; 2010 Oct; 104(10):1396-403. PubMed ID: 20580215
[TBL] [Abstract][Full Text] [Related]
12. The economic impact of acute exacerbations of chronic bronchitis in the United States and Canada: a literature review.
Halpern MT; Higashi MK; Bakst AW; Schmier JK
J Manag Care Pharm; 2003; 9(4):353-9. PubMed ID: 14613454
[TBL] [Abstract][Full Text] [Related]
13. Economic aspects of antimicrobial therapy of acute exacerbations of COPD.
Simoens S; Decramer M; Laekeman G
Respir Med; 2007 Jan; 101(1):15-26. PubMed ID: 16650975
[TBL] [Abstract][Full Text] [Related]
14. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis.
Destache CJ; Dewan N; O'Donohue WJ; Campbell JC; Angelillo VA
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():107-13. PubMed ID: 10225580
[TBL] [Abstract][Full Text] [Related]
15. Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis.
Martinez FJ; Anzueto A
Am J Med; 2005 Jul; 118 Suppl 7A():39S-44S. PubMed ID: 15993676
[TBL] [Abstract][Full Text] [Related]
16. Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Miravitlles M; Llor C; Naberan K; Cots JM; Molina J;
Respir Med; 2005 Aug; 99(8):955-65. PubMed ID: 15950136
[TBL] [Abstract][Full Text] [Related]
17. Development of a COPD severity score.
Wu EQ; Birnbaum HG; Cifaldi M; Kang Y; Mallet D; Colice G
Curr Med Res Opin; 2006 Sep; 22(9):1679-87. PubMed ID: 16968571
[TBL] [Abstract][Full Text] [Related]
18. Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD.
Anzueto A; Miravitlles M; Ewig S; Legnani D; Heldner S; Stauch K
Respir Med; 2012 Sep; 106(9):1258-67. PubMed ID: 22749710
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].
Bertrán MJ; Trilla A; Codina C; Carné X; Ribas J; Asenjo MA
Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168
[TBL] [Abstract][Full Text] [Related]
20. Costs of broad-spectrum antibiotic use for acute sinusitis, chronic bronchitis, and pneumonia in a managed care population.
Coughlin CM; Nelson M; Merchant S; Gondek K
Manag Care Interface; 2003 Jun; 16(6):34-40, 55. PubMed ID: 12841074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
